IMB-1680

N/A

Report date: 2023/04/01 22:49:13
NME

Base Information

Drug NameIMB-1680
Drug Alias NameIMB-1680
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet glycoprotein 4 inhibitors
TargetsPlatelet glycoprotein 4
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A